Abbott Labs Settles Trilipix Patent Litigation With Impax [ABT IS really busy lately] --Impax may begin selling generic Trilipix in 2014, or in 2013 under certain conditions --U.S. patent for Trilipix due to expire in 2025 --Companies say deal provides certainty, removes litigation risk http://online.wsj.com/article/BT-CO-20111020-711658.html?mod=wsj_share_twitter